Craig Garthwaite

Craig Garthwaite, a healthcare economics expert, Amanda Starc, who specializes in healthcare analytics, David Dranove, a health services authority, and Murray Ross from Kaiser Permanente discuss the American healthcare system’s misaligned incentives. They delve into the challenges patients face and share personal stories illustrating systemic failures. The conversation includes comparisons with Italy's healthcare model, the potential of preventive care, and the evolving roles of major companies like Amazon in the landscape, pushing for a collaborative approach to reform.

Craig Garthwaite, an economist and director at Northwestern's Kellogg School, dives into innovative solutions for Medicaid. He argues that the current focus on subsidies is too limited. Garthwaite discusses the potential of easing rules for foreign-trained doctors and allowing nurse practitioners to practice independently, which could significantly expand care. He advocates for state-based experimentation to implement reforms, highlighting how lowering costs could enhance access for low-income patients. These ideas promise a new direction for healthcare beyond mere coverage.

Join healthcare experts Craig Garthwaite, David Dranove, Paul Campbell, and Robert Lawton Burns as they dissect America's convoluted insurance landscape. They delve into the historical roots of employer-sponsored health insurance, revealing how economic factors shaped today’s system. The conversation explores the shift from traditional plans to HMOs and PPOs, and critiques the film 'John Q' for its reflection of healthcare struggles. Finally, they discuss the hurdles created by disincentives in healthcare investment and the confusion introduced by frequent job changes.

Join Amanda Starc and Craig Garthwaite from Kellogg School of Management, alongside Kevin Outterson from Boston University, as they delve into the economics of drug pricing and its impact on innovation. They discuss Medicare's new negotiating powers, the financial labyrinth of antibiotic development, and the challenges pharmaceutical companies face when balancing public health needs and sustainable business models. The conversation reveals the complex trade-offs between affordability and medical advancements that define modern healthcare.

Kellogg and Wharton professors discuss the rise of megaproviders in healthcare, the impact on costs and patient outcomes, challenges in regulating the industry, and the influence of mega providers on competition and healthcare services.